Atopic Dermatitis

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Sanofi is scrapping trials for an eczema drug derived from its billion-dollar acquisition of Kymab following a pipeline review.

5 sources 5 articles v 3 1h ago